4.4 Article

A novel method of generating prostate cancer metastases from orthotopic implants

Journal

PROSTATE
Volume 56, Issue 2, Pages 110-114

Publisher

WILEY-LISS
DOI: 10.1002/pros.10235

Keywords

prostate cancer; prostate specific antigen; xenografts; metastasis

Funding

  1. NIDDK NIH HHS [2 P0 DK47656-08] Funding Source: Medline

Ask authors/readers for more resources

BACKGROUND. Spontaneous metastasis following implantation at the orthotopic site is a highly desired feature in prostate cancer (CaP) models, since it would enable studies of mechanisms associated with tumor cell dissemination. METHODS. LuCaP 23.8 and LuCaP 35, hormone-sensitive CaP xenografts that express PSA and the wild-type androgen receptor, were grown orthotopically in SCID mice. When tumor volumes reached similar to250-500 mg, primary tumors were removed to allow micrometastases to grow. RESULTS. Using this procedure we generated macroscopic metastases (>20 mg) in 71% (LuCaP 23.8) and 100% (LuCaP 35) of animals, respectively. CONCLUSIONS. These models may be used to evaluate new treatment modalities and study mechanisms associated with development of metastases. (C) 2003 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available